Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2008 by National Cancer Institute (NCI). Recruitment status was Not yet recruiting
First Received on June 6, 2008. Last Updated on July 27, 2011 History of Changes
| Sponsor: | Gynecologic Oncology Group |
|---|---|
| Collaborator: | National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00693342 |
